Grandeur Peak Global Advisors’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-219,971
Closed -$3.64M 108
2017
Q2
$3.64M Buy
219,971
+7,480
+4% +$104K 0.53% 56
2017
Q1
$2.93M Buy
212,491
+190,541
+868% +$3.06M 0.48% 51
2016
Q4
$416K Hold
21,950
0.08% 94
2016
Q3
$487K Hold
21,950
0.09% 94
2016
Q2
$401K Buy
21,950
+15,050
+218% +$259K 0.09% 90
2016
Q1
$126K Buy
6,900
+1,525
+28% +$24.7K 0.03% 108
2015
Q4
$91K Buy
+5,375
New +$91.3K 0.02% 113

Other funds holding ENTL

Grandeur Peak Global Advisors's ENTL Position: Q3 2017 in Review

Grandeur Peak Global Advisors sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q3 2017, closing a stake of 219,971 shares — an estimated $3.64M sold.

Grandeur Peak Global Advisors first reported a position in ENTL in Q4 2015 and held it in 7 quarters. The position peaked at $3.64M in Q2 2017. 72 funds tracked by Wall St. Rank hold ENTL as of Q3 2017.

  • Grandeur Peak Global Advisors reported no remaining Entellus Medical, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Grandeur Peak Global Advisors sold 219,971 Entellus Medical, Inc. Common Stock shares in Q3 2017, an estimated $3.64M.
  • Grandeur Peak Global Advisors first reported a position in Entellus Medical, Inc. Common Stock in Q4 2015 and held it in 7 quarters.
  • Grandeur Peak Global Advisors's Entellus Medical, Inc. Common Stock position peaked at $3.64M in Q2 2017.
  • 72 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q3 2017.

Based on Grandeur Peak Global Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.